Search is Powered by Google
HIV / AIDS News

New York Times Examines Prevention Of Mother-to-Child HIV Transmission In South Africa

Main Category: HIV / AIDS
Also Included In: Pregnancy / Obstetrics;  Pediatrics / Children's Health
Article Date: 12 Mar 2008 - 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The New York Times on Sunday examined the South African government's adoption of a national treatment strategy to prevent mother-to-child HIV transmission. The country's Department of Health announced in January that it will begin requiring the World Health Organization -recommended strategy, which includes zidovudine and nevirapine.

Although some HIV/AIDS advocates are "celebrating the government's new policy," they also have said that South Africa "should have put it into practice long ago," the Times reports. Sibani Mngadi, a department of health spokesperson, said that the government had to review data and consult various people at WHO after the agency issued its guidelines in 2006. "There were a number of issues to be debated," he said (Dugger, New York Times, 3/9).

In related news, Reuters/Washington Post on Friday examined a recent government report that found a lack of financial resources could undermine the sustainability of South Africa's national HIV/AIDS plan. The report to the United Nations recently was posted on UNAIDS' Web site, and it was approved by the country's cabinet last week, according to Reuters/Washington Post. South Africa's national strategic plan aims to provide 80% of HIV-positive people with access to antiretroviral treatment by 2011. Figures from the health department indicate that it will cost about $747 million to implement this year -- increasing to $1.37 billion in 2011. The report said that if the plan's treatment target is met, "this would exceed 20% of the health budget," adding, "This poses a challenge for both the affordability and sustainability of" the plan. According to the report, it is "estimated that at current prices, the provision of antiretroviral therapy will account for about 40% of the total cost of the" plan. The report also said that there have been signs of reduced HIV prevalence among young pregnant women. "This could be the beginning of the long-awaited downward trend on prevalence among pregnant youth in South Africa," it said (Roelf, Reuters/Washington Post, 3/7).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


HIV and Cholesterol image HIV and Cholesterol

Elevated cholesterol can occur as a side effect from HIV treatments. Hear how one person with HIV steps up to the challenge of getting his cholesterol down...

Fast and Easy HIV Testing image Fast and Easy HIV Testing

Tests that can rapidly detect HIV are an important advancement in the fight against HIV and AIDS. Will these fast and easy tests lead to greater screening...

View more videos...